In the liver tissues of NAFLD rats, HULC inhibition improves lipid deposition and hepatic fibrosis and decreases hepatocyte apoptosis due to the inhibition of the mitogen-activated protein kinase (MAPK) signaling pathway [131]. Here, HULC is linked to metabolic dysfunction-associated steatotic liver disease.